Literature DB >> 6684934

Relationship between saliva levels of metamizol metabolites, bioavailability and analgesic efficacy.

P Rohdewald, G Drehsen, E Milsmann, H Derendorf.   

Abstract

Salivary levels of the metabolites of metamizol (N-methyl-, N-acetyl- and 4-aminoantipyrine) were determined after the intake of film-coated metamizol (Novalgin) tablets and metamizol (Novalgin) solution. Cortical evoked potentials, pain ratings and thresholds of sensation were monitored following tooth pulp stimulation after administration of metamizol tablets. Within the different groups of subjects a remarkable degree of reproducibility was obtained for the metabolite concentrations in saliva. At 20 min after drug intake a more rapid absorption was demonstrable for the solution in comparison to the tablets. The metabolite levels were correlated to the simultaneously recorded pain response demonstrating that the analgesic efficacy can only be attributed to the two metabolites N-methyl- and -4-amino-antipyrine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6684934

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  7 in total

1.  Novel bioactive metabolites of dipyrone (metamizol).

Authors:  Tobias Rogosch; Christian Sinning; Agnes Podlewski; Bernhard Watzer; Joel Schlosburg; Aron H Lichtman; Maria G Cascio; Tiziana Bisogno; Vincenzo Di Marzo; Rolf Nüsing; Peter Imming
Journal:  Bioorg Med Chem       Date:  2011-11-25       Impact factor: 3.641

Review 2.  Clinical pharmacokinetics of dipyrone and its metabolites.

Authors:  M Levy; E Zylber-Katz; B Rosenkranz
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

Review 3.  Pyrazolone derivatives.

Authors:  R N Brogden
Journal:  Drugs       Date:  1986       Impact factor: 9.546

4.  Effects of pentazocine and acetylsalicylic acid on pain-rating, pain-related evoked potentials and vigilance in relationship to pharmacokinetic parameters.

Authors:  G Kobal; C Hummel; B Nuernberg; K Brune
Journal:  Agents Actions       Date:  1990-03

5.  Effect of age on the pharmacokinetics of dipyrone.

Authors:  E Zylber-Katz; L Granit; J Stessman; M Levy
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  Dose evaluation of intravenous metamizole (dipyrone) in infants and children: a prospective population pharmacokinetic study.

Authors:  Victoria C Ziesenitz; Frédérique Rodieux; Andrew Atkinson; Carole Borter; Julia A Bielicki; Manuel Haschke; Urs Duthaler; Fabio Bachmann; Thomas O Erb; Nicolas Gürtler; Stefan Holland-Cunz; Johannes N van den Anker; Verena Gotta; Marc Pfister
Journal:  Eur J Clin Pharmacol       Date:  2019-08-07       Impact factor: 2.953

7.  Dose-dependent pharmacokinetics of metabolites of dipyrone in saliva.

Authors:  E Neddermann; P Rohdewald
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Apr-Jun       Impact factor: 2.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.